T1	tradename 0 7	DEPOCYT
T3	activeingredient 9 19	cytarabine
T5	nanoparticle 20 28	liposome
T7	tradename 155 169	DEPOCYT safely
T9	tradename 224 241	DEPOCYT.  DEPOCYT
T11	activeingredient 243 253	cytarabine
T13	nanoparticle 254 262	liposome
T15	routeofadministration 280 291	Intrathecal
T17	fdaapprovaldate 324 328	1999
T19	tradename 443 444	 
T21	adversereaction 444 466	Chemical arachnoiditis
T23	adversereaction 503 509	nausea
T25	adversereaction 511 519	vomiting
T27	adversereaction 521 529	headache
T29	adversereaction 534 539	fever
T31	adversereaction 613 635	chemical arachnoiditis
T33	tradename 669 676	DepoCyt
T35	co-administereddrug 713 726	dexamethasone
T37	adversereaction 755 778	chemical arachnoiditis.
T39	tradename 869 877	 DepoCyt
T41	routeofadministration 899 910	intrathecal
T43	indication 924 948	lymphomatous meningitis.
T45	tradename 1025 1033	 DepoCyt
T47	routeofadministration 1041 1052	intrathecal
T49	tradename 1089 1096	DepoCyt
T51	dose 1098 1103	50 mg
T53	routeofadministration 1116 1129	intrathecally
T55	frequency 1168 1181	every 14 days
T57	tradename 1240 1247	DepoCyt
T59	dose 1249 1254	50 mg
T61	routeofadministration 1267 1280	intrathecally
T63	frequency 1319 1332	every 14 days
T65	tradename 1424 1431	DepoCyt
T67	dose 1433 1438	50 mg
T69	routeofadministration 1451 1464	intrathecally
T71	frequency 1503 1516	every 28 days
T73	co-administereddrug 1571 1584	dexamethasone
T75	dose 1585 1589	4 mg
T77	frequency 1590 1601	twice a day
T79	routeofadministration 1609 1617	by mouth
T81	routeofadministration 1621 1634	intravenously
T83	tradename 1670 1677	DepoCyt
T85	tradename 1737 1744	DepoCyt
T87	dose 1748 1754	25 mg.
T89	tradename 1794 1802	DepoCyt.
T91	activeingredient 1933 1943	cytarabine
T93	nanoparticle 1944 1952	liposome
T95	activeingredient 2065 2075	cytarabine
T97	adversereaction 2237 2247	Myelopathy
T99	tradename 2320 2328	DepoCyt.
T101	tradename 2459 2467	DepoCyt.
T103	adversereaction 2614 2622	headache
T105	adversereaction 2624 2637	arachnoiditis
T107	adversereaction 2639 2648	confusion
T109	adversereaction 2650 2663	abnormal gait
T111	adversereaction 2666 2677	convulsions
T113	adversereaction 2679 2687	weakness
T115	adversereaction 2689 2696	pyrexia
T117	adversereaction 2698 2705	fatigue
T119	adversereaction 2707 2713	nausea
T121	adversereaction 2715 2723	vomiting
T123	adversereaction 2726 2738	constipation
T125	adversereaction 2744 2754	back pain.
T127	company 2809 2818	Sigma-Tau
T129	company 2820 2835	Pharmaceuticals
T131	company 2837 2841	Inc.
T133	adversereaction 3316 3338	Chemical Arachnoiditis
T135	adversereaction 4212 4234	CHEMICAL ARACHNOIDITIS
T137	tradename 4254 4255	 
T139	adversereaction 4255 4277	Chemical arachnoiditis
T141	adversereaction 4314 4320	nausea
T143	adversereaction 4322 4330	vomiting
T145	adversereaction 4332 4340	headache
T147	adversereaction 4345 4350	fever
T149	adversereaction 4424 4446	chemical arachnoiditis
T151	tradename 4480 4487	DepoCyt
T153	co-administereddrug 4524 4537	dexamethasone
T155	adversereaction 4566 4589	chemical arachnoiditis.
T157	tradename 4658 4668	 DepoCyt (
T159	activeingredient 4668 4678	cytarabine
T161	nanoparticle 4679 4687	liposome
T163	routeofadministration 4720 4731	intrathecal
T165	indication 4745 4769	lymphomatous meningitis.
T167	tradename 4849 4857	 DepoCyt
T169	tradename 4972 4982	DepoCyt. 
T171	tradename 5019 5026	DepoCyt
T173	tradename 5246 5253	DepoCyt
T175	tradename 5311 5318	DepoCyt
T177	tradename 5501 5508	DepoCyt
T179	tradename 5578 5585	DepoCyt
T181	tradename 5648 5655	DepoCyt
T183	tradename 5890 5897	DepoCyt
T185	tradename 6004 6020	DepoCyt. DepoCyt
T187	routeofadministration 6121 6158	direct injection into the lumbar sac.
T189	tradename 6160 6167	DepoCyt
T191	indication 6451 6474	lymphomatous meningitis
T193	tradename 6476 6483	DepoCyt
T195	dose 6484 6489	50 mg
T197	tradename 6503 6511	DepoCyt)
T199	tradename 6595 6602	DepoCyt
T201	dose 6604 6609	50 mg
T203	routeofadministration 6624 6637	intrathecally
T205	routeofadministration 6659 6675	lumbar puncture)
T207	frequency 6676 6689	every 14 days
T209	tradename 6742 6749	DepoCyt
T211	dose 6751 6756	50 mg
T213	routeofadministration 6771 6784	intrathecally
T215	routeofadministration 6806 6822	lumbar puncture)
T217	frequency 6823 6836	every 14 days
T219	tradename 6923 6930	DepoCyt
T221	dose 6932 6937	50 mg
T223	routeofadministration 6952 6965	intrathecally
T225	routeofadministration 6987 7003	lumbar puncture)
T227	frequency 7004 7017	every 28 days
T229	co-administereddrug 7088 7101	dexamethasone
T231	dose 7102 7106	4 mg
T233	frequency 7107 7118	twice a day
T235	routeofadministration 7126 7134	by mouth
T237	routeofadministration 7138 7151	intravenously
T239	duration 7156 7162	5 days
T241	tradename 7187 7194	DepoCyt
T243	dose 7277 7283	25 mg.
T245	tradename 7315 7322	DepoCyt
T247	activeingredient 7447 7457	cytarabine
T249	nanoparticle 7458 7466	liposome
T251	tradename 7502 7512	 DepoCyt (
T253	activeingredient 7512 7522	cytarabine
T255	nanoparticle 7523 7531	liposome
T257	activeingredient 7600 7610	cytarabine
T259	adversereaction 7730 7752	Chemical Arachnoiditis
T261	tradename 7754 7755	 
T263	adversereaction 7755 7777	Chemical arachnoiditis
T265	adversereaction 7814 7820	nausea
T267	adversereaction 7822 7830	vomiting
T269	adversereaction 7832 7840	headache
T271	adversereaction 7845 7850	fever
T273	adversereaction 7904 7926	chemical arachnoiditis
T275	adversereaction 8026 8048	chemical arachnoiditis
T277	adversereaction 8094 8116	chemical arachnoiditis
T279	tradename 8190 8197	DepoCyt
T281	co-administereddrug 8234 8247	dexamethasone
T283	adversereaction 8276 8298	chemical arachnoiditis
T285	routeofadministration 8574 8585	intrathecal
T287	tradename 8599 8606	DepoCyt
T289	adversereaction 8663 8677	neurotoxicity.
T291	adversereaction 8699 8712	neurotoxicity
T293	tradename 8741 8751	DepoCyt. 
T295	tradename 8790 8797	DepoCyt
T297	adversereaction 8836 8849	Hydrocephalus
T299	adversereaction 8899 8913	arachnoiditis.
T301	adversereaction 8915 8928	Arachnoiditis
T303	routeofadministration 9013 9024	intrathecal
T305	adversereaction 9085 9098	arachnoiditis
T307	tradename 9121 9128	DepoCyt
T309	indication 9195 9219	lymphomatous meningitis.
T311	adversereaction 9254 9276	chemical arachnoiditis
T313	co-administereddrug 9316 9329	dexamethasone
T315	co-administereddrug 9360 9373	dexamethasone
T317	adversereaction 9392 9414	chemical arachnoiditis
T319	adversereaction 9451 9464	Neurotoxicity
T321	tradename 9466 9467	 
T323	routeofadministration 9467 9478	Intrathecal
T325	activeingredient 9497 9507	cytarabine
T327	adversereaction 9518 9528	myelopathy
T329	adversereaction 9539 9558	neurologic toxicity
T331	routeofadministration 9632 9643	intrathecal
T333	activeingredient 9644 9654	cytarabine
T335	adversereaction 9766 9780	neurotoxicity.
T337	activeingredient 9832 9842	cytarabine
T339	adversereaction 9894 9908	neurotoxicity.
T341	routeofadministration 9933 9944	intrathecal
T343	routeofadministration 10073 10084	intrathecal
T345	tradename 10103 10110	DepoCyt
T347	adversereaction 10112 10143	central nervous system toxicity
T349	adversereaction 10155 10184	persistent extreme somnolence
T351	adversereaction 10186 10196	hemiplegia
T353	adversereaction 10198 10217	visual disturbances
T355	adversereaction 10228 10237	blindness
T357	adversereaction 10272 10280	deafness
T359	adversereaction 10285 10306	cranial nerve palsies
T361	adversereaction 10349 10370	peripheral neuropathy
T363	adversereaction 10380 10384	pain
T365	adversereaction 10386 10394	numbness
T367	adversereaction 10396 10407	paresthesia
T369	adversereaction 10409 10417	weakness
T371	adversereaction 10423 10457	impaired bowel and bladder control
T373	adversereaction 10569 10591	Cauda Equina Syndrome.
T375	adversereaction 10613 10626	neurotoxicity
T377	tradename 10655 10662	DepoCyt
T379	tradename 10678 10685	DepoCyt
T381	adversereaction 10686 10694	Headache
T383	adversereaction 10696 10702	nausea
T385	adversereaction 10708 10713	fever
T387	adversereaction 10745 10759	neurotoxicity.
T389	tradename 10934 10941	DepoCyt
T391	tradename 10986 10987	 
T393	activeingredient 10987 10997	Cytarabine
T395	tradename 11023 11030	DepoCyt
T397	activeingredient 11136 11146	cytarabine
T399	routeofadministration 11157 11168	intrathecal
T401	tradename 11187 11194	DepoCyt
T403	activeingredient 11211 11221	Cytarabine
T405	activeingredient 11256 11266	Cytarabine
T407	adversereaction 11681 11703	Chemical Arachnoiditis
T409	adversereaction 11742 11755	Neurotoxicity
T411	adversereaction 11794 11855	Transient elevations in CSF protein and CSF white blood cells
T413	routeofadministration 11941 11952	intrathecal
T415	activeingredient 11971 11981	cytarabine
T417	adversereaction 12042 12050	headache
T419	adversereaction 12056 12062	nausea
T421	adversereaction 12064 12072	vomiting
T423	adversereaction 12078 12091	arachnoiditis
T425	adversereaction 12093 12101	weakness
T427	adversereaction 12103 12112	confusion
T429	adversereaction 12114 12121	pyrexia
T431	adversereaction 12123 12130	fatigue
T433	adversereaction 12132 12144	constipation
T435	adversereaction 12146 12155	back pain
T437	adversereaction 12157 12170	gait abnormal
T439	adversereaction 12176 12187	convulsions
T441	adversereaction 12193 12202	dizziness
T443	adversereaction 12208 12216	lethargy
T445	adversereaction 12218 12230	pain in limb
T447	adversereaction 12232 12240	insomnia
T449	adversereaction 12242 12265	urinary tract infection
T451	adversereaction 12271 12280	neck pain
T453	adversereaction 12282 12287	death
T455	adversereaction 12293 12297	pain
T457	adversereaction 12299 12316	memory impairment
T459	adversereaction 12318 12329	dehydration
T461	adversereaction 12331 12337	anemia
T463	adversereaction 12343 12351	diarrhea
T465	adversereaction 12357 12375	appetite decreased
T467	adversereaction 12381 12397	thrombocytopenia
T469	adversereaction 12399 12415	edema peripheral
T471	adversereaction 12417 12427	arthralgia
T473	adversereaction 12429 12443	neck stiffness
T475	adversereaction 12445 12459	vision blurred
T477	adversereaction 12461 12476	muscle weakness
T479	adversereaction 12478 12489	neutropenia
T481	adversereaction 12491 12503	hypoesthesia
T483	adversereaction 12505 12514	agitation
T485	adversereaction 12520 12527	dyspnea
T487	indication 13243 13266	lymphomatous meningitis
T489	tradename 13277 13284	DepoCyt
T491	dose 13285 13290	50 mg
T493	tradename 13366 13373	DepoCyt
T495	tradename 13382 13389	DepoCyt
T497	tradename 13438 13439	 
T499	adversereaction 13439 13447	Headache
T501	adversereaction 13480 13493	Arachnoiditis
T503	adversereaction 13523 13532	Confusion
T505	adversereaction 13561 13574	Gait abnormal
T507	adversereaction 13606 13617	Convulsions
T509	adversereaction 13647 13656	Dizziness
T511	adversereaction 13687 13704	Memory impairment
T513	adversereaction 13730 13742	Hypoesthesia
T515	adversereaction 13769 13775	Tremor
T517	adversereaction 13801 13822	Peripheral neuropathy
T519	adversereaction 13850 13857	Syncope
T521	adversereaction 13882 13892	Neuropathy
T523	adversereaction 13921 13950	Peripheral sensory neuropathy
T525	adversereaction 13975 13992	Reflexes abnormal
T527	tradename 14072 14073	 
T529	adversereaction 14073 14081	Weakness
T531	adversereaction 14111 14118	Pyrexia
T533	adversereaction 14147 14154	Fatigue
T535	adversereaction 14182 14190	Lethargy
T537	adversereaction 14217 14222	Death
T539	tradename 14253 14254	 
T541	adversereaction 14254 14262	Lymphoma
T543	tradename 14303 14310	DepoCyt
T545	tradename 14319 14326	DepoCyt
T547	tradename 14348 14349	 
T549	adversereaction 14349 14353	Pain
T551	adversereaction 14383 14399	Edema peripheral
T553	adversereaction 14427 14431	Fall
T555	adversereaction 14456 14476	Mucosal inflammation
T557	adversereaction 14504 14509	Edema
T559	adversereaction 14565 14571	Nausea
T561	adversereaction 14601 14609	Vomiting
T563	adversereaction 14642 14654	Constipation
T565	adversereaction 14681 14689	Diarrhea
T567	adversereaction 14720 14734	Abdominal pain
T569	adversereaction 14764 14773	Dysphagia
T571	adversereaction 14799 14810	Hemorrhoids
T573	adversereaction 14885 14894	Back pain
T575	adversereaction 14921 14933	Pain in limb
T577	adversereaction 14960 14969	Neck pain
T579	adversereaction 14996 15006	Arthralgia
T581	adversereaction 15032 15046	Neck stiffness
T583	adversereaction 15072 15087	Muscle weakness
T585	adversereaction 15140 15148	Insomnia
T587	adversereaction 15175 15184	Agitation
T589	adversereaction 15210 15220	Depression
T591	adversereaction 15246 15253	Anxiety
T593	adversereaction 15307 15330	Urinary tract infection
T595	adversereaction 15361 15370	Pneumonia
T597	adversereaction 15435 15446	Dehydration
T599	adversereaction 15473 15491	Appetite decreased
T601	adversereaction 15522 15534	Hyponatremia
T603	adversereaction 15559 15570	Hypokalemia
T605	adversereaction 15595 15608	Hyperglycemia
T607	adversereaction 15633 15641	Anorexia
T609	adversereaction 15682 15706	Platelet count decreased
T611	adversereaction 15760 15772	Incontinence
T613	adversereaction 15801 15818	Urinary retention
T615	adversereaction 15893 15900	Dyspnea
T617	adversereaction 15931 15936	Cough
T619	adversereaction 15976 15990	Vision blurred
T621	adversereaction 16048 16054	Anemia
T623	adversereaction 16085 16101	Thrombocytopenia
T625	tradename 16178 16185	DepoCyt
T627	tradename 16194 16201	DepoCyt
T629	tradename 16223 16224	 
T631	adversereaction 16224 16235	Neutropenia
T633	tradename 16304 16305	 
T635	adversereaction 16305 16314	Contusion
T637	adversereaction 16339 16347	Pruritus
T639	adversereaction 16375 16393	Sweating increased
T641	adversereaction 16438 16449	Hypotension
T643	adversereaction 16478 16490	Hypertension
T645	adversereaction 16548 16557	Hypacusis
T647	adversereaction 16602 16613	Tachycardia
T649	adversereaction 16712 16741	Diffuse Large B-Cell Lymphoma
T651	tradename 16912 16919	DepoCyt
T653	dose 16920 16925	50 mg
T655	tradename 16987 16995	 DepoCyt
T657	tradename 17055 17057	 
T659	adversereaction 17057 17065	Headache
T661	adversereaction 17098 17111	Arachnoiditis
T663	adversereaction 17141 17152	Convulsions
T665	adversereaction 17211 17217	Nausea
T667	adversereaction 17246 17254	Vomiting
T669	adversereaction 17336 17345	Back pain
T671	adversereaction 17372 17381	Neck pain
T673	adversereaction 17406 17420	Neck stiffness
T675	adversereaction 17499 17506	Pyrexia
T677	tradename 17658 17665	DepoCyt
T679	adversereaction 17722 17728	deaths
T681	tradename 17740 17747	DepoCyt
T683	dose 17782 17788	125 mg
T685	adversereaction 17808 17822	encephalopathy
T687	routeofadministration 17851 17867	intraventricular
T689	tradename 17876 17886	DepoCyt. 
T691	tradename 18051 18058	DepoCyt
T693	dose 18060 18065	50 mg
T695	routeofadministration 18073 18089	intraventricular
T697	adversereaction 18110 18124	focal seizures
T699	adversereaction 18140 18159	status epilepticus.
T701	adversereaction 18302 18310	seizures
T703	tradename 18329 18336	DepoCyt
T705	activeingredient 18369 18379	cytarabine
T707	adversereaction 18405 18410	death
T709	tradename 18472 18480	DepoCyt.
T711	tradename 18680 18690	DepoCyt.  
T713	tradename 18784 18791	DepoCyt
T715	tradename 18860 18867	DepoCyt
T717	routeofadministration 18921 18932	intrathecal
T719	routeofadministration 18967 18978	intrathecal
T721	activeingredient 18979 18989	cytarabine
T723	routeofadministration 19030 19043	intrathecally
T725	adversereaction 19054 19067	neurotoxicity
T727	tradename 19289 19299	DepoCyt. 
T729	activeingredient 19324 19334	cytarabine
T731	routeofadministration 19345 19356	intrathecal
T733	tradename 19375 19382	DepoCyt
T735	activeingredient 19398 19408	Cytarabine
T737	activeingredient 19609 19619	cytarabine
T739	tradename 19775 19786	DepoCyt. 
T741	tradename 19961 19962	 
T743	activeingredient 19962 19972	Cytarabine
T745	dose 20080 20087	2 mg/kg
T747	frequency 20087 20091	/day
T749	routeofadministration 20110 20112	IP
T751	dose 20250 20258	20 mg/kg
T753	routeofadministration 20288 20290	IP
T755	routeofadministration 20388 20390	IP
T757	dose 20400 20408	50 mg/kg
T759	tradename 20589 20591	 
T761	activeingredient 20591 20601	Cytarabine
T763	dose 20744 20753	0.5 mg/kg
T765	frequency 20753 20757	/day
T767	dose 20896 20903	8 mg/kg
T769	frequency 20903 20907	/day
T771	activeingredient 21023 21033	cytarabine
T773	routeofadministration 21070 21081	intrathecal
T775	tradename 21082 21089	DepoCyt
T777	activeingredient 21137 21147	cytarabine
T779	routeofadministration 21158 21169	intrathecal
T781	tradename 21185 21192	DepoCyt
T783	tradename 21529 21536	DepoCyt
T785	tradename 21690 21697	DepoCyt
T787	tradename 21758 21765	DepoCyt
T789	activeingredient 21770 21780	cytarabine
T791	nanoparticle 21781 21789	liposome
T793	tradename 21839 21846	DepoCyt
T795	adversereaction 21877 21899	chemical arachnoiditis
T797	adversereaction 21910 21925	encephalopathy.
T799	co-administereddrug 21966 21979	dexamethasone
T801	dose 22012 22018	125 mg
T803	routeofadministration 22075 22086	intrathecal
T805	tradename 22087 22094	DepoCyt
T807	activeingredient 22113 22123	cytarabine
T809	tradename 22138 22148	DepoCyt. 
T811	routeofadministration 22219 22230	intrathecal
T813	activeingredient 22248 22258	cytarabine
T815	tradename 22314 22321	DepoCyt
T817	tradename 22425 22435	 DepoCyt (
T819	activeingredient 22435 22445	cytarabine
T821	nanoparticle 22446 22454	liposome
T823	chemoclass 22509 22523	antimetabolite
T825	activeingredient 22524 22534	cytarabine
T827	routeofadministration 22539 22550	intrathecal
T829	activeingredient 22590 22600	cytarabine
T831	molecularweight 22761 22774	243.22 g/mol.
T833	activeingredient 22775 22785	Cytarabine
T835	tradename 22825 22832	DepoCyt
T837	activeingredient 22904 22915	cytarabine.
T839	tradename 22916 22923	DepoCyt
T841	activeingredient 23000 23010	cytarabine
T843	nanoparticle 23011 23020	liposomes
T845	inactiveingredient 23033 23048	sodium chloride
T847	inactiveingredient 23052 23057	water
T849	activeingredient 23098 23108	cytarabine
T851	corecomposition 23117 23128	cholesterol
T853	corecomposition 23154 23188	dioleoylphosphatidylcholine (DOPC)
T855	corecomposition 23201 23240	dipalmitoylphosphatidylglycerol (DPPG).
T857	tradename 23242 23249	DepoCyt
T859	nanoparticle 23336 23344	Liposome
T861	activeingredient 23424 23434	cytarabine
T863	nanoparticle 23435 23443	liposome
T865	activeingredient 23539 23550	cytarabine.
T867	tradename 23604 23612	 DepoCyt
T869	activeingredient 23614 23624	cytarabine
T871	nanoparticle 23625 23633	liposome
T873	activeingredient 23705 23715	cytarabine
T875	activeingredient 23788 23798	Cytarabine
T877	activeingredient 23928 23938	cytarabine
T879	activeingredient 23957 23968	cytarabine-
T881	activeingredient 24218 24228	cytarabine
T883	activeingredient 24243 24253	Cytarabine
T885	routeofadministration 24347 24358	intrathecal
T887	tradename 24377 24384	DepoCyt
T889	dose 24385 24390	50 mg
T891	activeingredient 24416 24426	cytarabine
T893	tmax 24441 24454	within 1 hour
T895	cmax 24481 24497	30 to 50 mcg/mL.
T897	activeingredient 24539 24549	cytarabine
T899	plasmahalflife 24565 24583	5.9 to 82.4 hours.
T901	activeingredient 24606 24616	cytarabine
T903	routeofadministration 24642 24653	intrathecal
T905	tradename 24672 24679	DepoCyt
T907	dose 24680 24686	50 mg.
T909	activeingredient 24753 24763	cytarabine
T911	activeingredient 24892 24902	cytarabine
T913	routeofadministration 24994 25005	intrathecal
T915	activeingredient 25139 25149	cytarabine
T917	tradename 25384 25394	DepoCyt. 
T919	activeingredient 25394 25404	Cytarabine
T921	activeingredient 25620 25630	Cytarabine
T923	activeingredient 25745 25755	cytarabine
T925	activeingredient 25803 25813	Cytarabine
T927	routeofadministration 25953 25955	IP
T929	activeingredient 25956 25967	cytarabine.
T931	activeingredient 26006 26016	cytarabine
T933	routeofadministration 26027 26038	intrathecal
T935	tradename 26054 26061	DepoCyt
T937	tradename 26127 26134	DepoCyt
T939	tradename 26178 26186	 DepoCyt
T941	activeingredient 26188 26198	cytarabine
T943	dose 26492 26497	50 mg
T945	tradename 26501 26508	DepoCyt
T947	frequency 26522 26535	every 2 weeks
T949	routeofadministration 26548 26559	intrathecal
T951	frequency 26586 26598	twice a week
T953	dose 26712 26717	50 mg
T955	activeingredient 26736 26746	cytarabine
T957	frequency 26753 26766	twice a week.
T959	tradename 26803 26810	DepoCyt
T961	activeingredient 26815 26826	cytarabine)
T963	tradename 27671 27678	DepoCyt
T965	tradename 27897 27904	DepoCyt
T967	activeingredient 27930 27940	cytarabine
T969	tradename 28304 28311	DepoCyt
T971	activeingredient 28315 28326	cytarabine.
T973	tradename 28377 28384	DepoCyt
T975	duration 28385 28390	50 mg
T977	frequency 28391 28404	every 2 weeks
T979	activeingredient 28408 28418	cytarabine
T981	dose 28419 28424	50 mg
T983	frequency 28425 28438	twice weekly.
T985	tradename 28490 28497	DepoCyt
T987	dose 28498 28503	50 mg
T989	frequency 28504 28517	every 4 weeks
T991	activeingredient 28522 28532	cytarabine
T993	dose 28533 28538	50 mg
T995	frequency 28539 28545	weekly
T997	duration 28550 28558	4 weeks.
T999	co-administereddrug 28621 28634	dexamethasone
T1001	adversereaction 28672 28694	chemical arachnoiditis
T1003	indication 28919 28942	lymphomatous meningitis
T1005	indication 29023 29046	Lymphomatous Meningitis
T1007	tradename 29047 29056	 DepoCyt
T1009	activeingredient 29057 29067	Cytarabine
T1011	tradename 29363 29370	DepoCyt
T1013	activeingredient 29372 29382	cytarabine
T1015	nanoparticle 29383 29391	liposome
T1017	tradename 29739 29748	 DepoCyt
T1019	adversereaction 29938 29946	headache
T1021	adversereaction 29948 29954	nausea
T1023	adversereaction 29956 29964	vomiting
T1025	adversereaction 29970 29975	fever
T1027	adversereaction 30019 30033	neurotoxicity.
T1029	co-administereddrug 30083 30096	dexamethasone
T1031	tradename 30168 30175	DepoCyt
T1033	co-administereddrug 30259 30272	neurotoxicity
T1035	routeofadministration 30288 30292	oral
T1037	co-administereddrug 30293 30306	dexamethasone
T1039	company 30368 30393	Sigma-Tau Pharmaceuticals
T1041	company 30395 30399	Inc.
T1043	company 30439 30461	Pacira Pharmaceuticals
T1045	company 30463 30467	Inc.
T1047	company 30507 30532	Sigma-Tau Pharmaceuticals
T1049	company 30534 30538	Inc.
T1051	u.s.patent 30583 30584	5
T1053	u.s.patent 30585 30588	807
T1055	u.s.patent 30589 30592	572
T1057	u.s.patent 30594 30595	5
T1059	u.s.patent 30596 30599	723
T1061	u.s.patent 30600 30603	147
T1063	u.s.patent 30605 30606	5
T1065	u.s.patent 30607 30610	455
T1067	u.s.patent 30611 30614	044
T1069	u.s.patent 30616 30617	5
T1071	u.s.patent 30618 30621	891
T1073	u.s.patent 30622 30625	467
